Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
December 2013 Volume 30 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December 2013 Volume 30 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells

  • Authors:
    • Wei Zhou
    • Mao Sun
    • Dong-Lin Wang
    • Ying Wang
    • Fu Jin
    • Yun-Yun Zhang
    • Li Yang
    • Xiao-Ling Wu
    • Yong-Zhong Wu
  • View Affiliations / Copyright

    Affiliations: Department of Radiotherapy, Chongqing Cancer Institute, Chongqing 400011, P.R. China, Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China, Department of Oncology, Chongqing Cancer Institute, Chongqing 400011, P.R. China, School of Bioengineering, Chongqing University, Chongqing 400044, P.R. China
  • Pages: 2685-2690
    |
    Published online on: September 20, 2013
       https://doi.org/10.3892/or.2013.2745
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Regenerating islet-derived family member 4 (RegIV) is overexpressed in several types of tumours, including pancreatic and gastric cancer (GC). However, the role it plays in gastric cancer stem cells (GCSCs) remains unknown. The present study tested the hypothesis that the silencing of RegIV by shRNA in GC cells may cause the loss of their stemness properties, indicating the inhibition of growth, proliferation and increased sensitivity to chemoradiation-induced cell death. MKN45 poorly differentiated human GC cells were propagated as mammospheres in stem cell culture conditions. Mammospheres were identified as CSCs using generally acknowledged CSC markers such as CD44. A panel of 21-nucleotide shRNAs were designed to target RegIV gene expression. Several shRNA constructs were identified that led to significant reduction in RegIV mRNA expression. Furthermore, the stemness properties of control mammospheres and RegIV knockdown mammospheres were compared by tumourigenicity assay in vivo and plate colony formation assay in vitro. Finally, we evaluated the treatment response in both mammospheres which underwent chemoradiation. The knockdown expression of RegIV by shRNA deprived CSCs of their stemness properties and increased the effectiveness of cell killing following chemoradiation. Inhibition of endogenous RegIV expression may be a new therapeutic strategy for human GC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar

2 

Bianchi A and Espin F: Where are we in the treatment of gastric cancer? Experiences and evidences 30 years later. Med Clin (Barc). 140:307–309. 2012.(In Spanish).

3 

Zhang CJ, Li CW, Yang H and He FT: Cancer stem cells in gastric cancer. Zhongguo Shengwu Huaxue Yu Fenzi Shengwu Xuebao. 25:889–895. 2009.(In Chinese).

4 

Kelleher FC: Hedgehog signaling and therapeutics in pancreatic cancer. Carcinogenesis. 32:445–451. 2011. View Article : Google Scholar : PubMed/NCBI

5 

Granlund AvB, Beisvag V, Torp SH, et al: Activation of REG family proteins in colitis. Scand J Gastroenterol. 46:1316–1323. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Luo Q, Bishnupuri KS, Houchen C, Anant S and Dieckgraefe BK: Silencing of the regenerating IV (Reg IV) gene by siRNA inhibits the growth and proliferation of human colon adenocarcinomas. Gastroenterology. 130:A5332006.

7 

Ying LS, Yu JL, Lu XX and Ling ZQ: Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer. Dig Dis Sci. 58:414–422. 2012.

8 

Moon J-H, Fujiwara Y, Nakamura Y, et al: REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma. J Surg Oncol. 105:189–194. 2012. View Article : Google Scholar : PubMed/NCBI

9 

Miyagawa K, Sakakura C, Nakashima S, et al: Overexpression of RegIV in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastasis. Anticancer Res. 28:1169–1179. 2008.

10 

Kuniyasu H, Oue N, Sasahira T, et al: Reg IV enhances peritoneal metastasis in gastric carcinomas. Cell Prolif. 42:110–121. 2009. View Article : Google Scholar

11 

Olive PL, Banath JP and Durand RE: Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the ‘comet’ assay. Radiat Res. 178:AV35–AV42. 2012.

12 

Gilbert CA and Ross AH: Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem. 108:1031–1038. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Takaishi S, Okumura T, Tu S, et al: Isolation of gastric cancer-initiating cells using cell surface marker CD44. Gastroenterology. 132:A632–A633. 2007.

14 

Yasui W, Sentani K, Motoshita J and Nakayama H: Molecular pathobiology of gastric cancer. Scand J Surg. 95:225–231. 2006.

15 

Kadowaki Y, Ishihara S, Miyaoka Y, et al: Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth. FEBS Lett. 530:59–64. 2002. View Article : Google Scholar : PubMed/NCBI

16 

Guo Y, Xu J, Li N, Gao F and Huang P: RegIV potentiates colorectal carcinoma cell migration and invasion via its CRD domain. Cancer Genet Cytogenet. 199:38–44. 2010. View Article : Google Scholar

17 

Kuniyasu H, Kitadai Y, Oue N, Sasahira T, Ohmori H and Yasui W: Increased peritoneal metastasis of reg IV-transfected MKN28 gastric carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting. 48:11092007.

18 

Numata M, Oshima T, Yoshihara K, et al: Relationship between RegIV gene expression to outcomes in colorectal cancer. J Surg Oncol. 104:205–209. 2011.

19 

Oue N, Hamai Y, Mitani Y, et al: Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res. 64:2397–2405. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Li FY, Ren XB, Xu EP, et al: RegIV expression showing specificity to gastrointestinal tract and its potential role in diagnosing digestive tract neuroendocrine tumor. J Zhejiang Univ Sci B. 11:258–266. 2010. View Article : Google Scholar

21 

Heiskala K, Arola J and Andersson L: Expression of RegIV and Hath1 in neuroendocrine tumors. Virchows Archiv. 452:S75–S76. 2008.

22 

Lee JY, Eom EM, Kim DS, Ha-Lee YM and Lee DH: Analysis of gene expression profiles of gastric normal and cancer tissues by SAGE. Genomics. 82:78–85. 2003. View Article : Google Scholar : PubMed/NCBI

23 

Vanderlaag K, Wang W, Fayadat-Dilman L, et al: Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer. Int J Cancer. 130:1251–1263. 2012. View Article : Google Scholar : PubMed/NCBI

24 

Wang F, Xu L, Guo C, et al: Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PLoS One. 6:e184342011. View Article : Google Scholar : PubMed/NCBI

25 

Hambardzumyan D, Becher OJ and Holland EC: Cancer stem cells and survival pathways. Cell Cycle. 7:1371–1378. 2008. View Article : Google Scholar

26 

Suda T, Arai F and Hirao A: Hematopoietic stem cells and their niche. Trends Immunol. 26:426–433. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Spillane JB and Henderson MA: Cancer stem cells: a review. ANZ J Surg. 77:464–468. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Moon SH, Kim DK, Cha Y, Jeon I, Song J and Park KS: PI3K/Akt and Stat3 signaling regulated by PTEN control of the cancer stem cell population, proliferation and senescence in a glioblastoma cell line. Int J Oncol. 42:921–928. 2013.PubMed/NCBI

29 

Lee SH, Hong HS, Liu ZX, et al: TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem Biophys Res Commun. 424:58–64. 2012.

30 

Rodova M, Fu J, Watkins DN, Srivastava RK and Shankar S: Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal. PLoS One. 7:e460832012. View Article : Google Scholar : PubMed/NCBI

31 

Merchant AA and Matsui W: Targeting Hedgehog - a cancer stem cell pathway. Clin Cancer Res. 16:3130–3140. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Martin J, Donnelly JM, Houghton J and Zavros Y: The role of sonic hedgehog reemergence during gastric cancer. Dig Dis Sci. 55:1516–1524. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhou W, Sun M, Wang D, Wang Y, Jin F, Zhang Y, Yang L, Wu X and Wu Y: Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells. Oncol Rep 30: 2685-2690, 2013.
APA
Zhou, W., Sun, M., Wang, D., Wang, Y., Jin, F., Zhang, Y. ... Wu, Y. (2013). Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells. Oncology Reports, 30, 2685-2690. https://doi.org/10.3892/or.2013.2745
MLA
Zhou, W., Sun, M., Wang, D., Wang, Y., Jin, F., Zhang, Y., Yang, L., Wu, X., Wu, Y."Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells". Oncology Reports 30.6 (2013): 2685-2690.
Chicago
Zhou, W., Sun, M., Wang, D., Wang, Y., Jin, F., Zhang, Y., Yang, L., Wu, X., Wu, Y."Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells". Oncology Reports 30, no. 6 (2013): 2685-2690. https://doi.org/10.3892/or.2013.2745
Copy and paste a formatted citation
x
Spandidos Publications style
Zhou W, Sun M, Wang D, Wang Y, Jin F, Zhang Y, Yang L, Wu X and Wu Y: Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells. Oncol Rep 30: 2685-2690, 2013.
APA
Zhou, W., Sun, M., Wang, D., Wang, Y., Jin, F., Zhang, Y. ... Wu, Y. (2013). Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells. Oncology Reports, 30, 2685-2690. https://doi.org/10.3892/or.2013.2745
MLA
Zhou, W., Sun, M., Wang, D., Wang, Y., Jin, F., Zhang, Y., Yang, L., Wu, X., Wu, Y."Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells". Oncology Reports 30.6 (2013): 2685-2690.
Chicago
Zhou, W., Sun, M., Wang, D., Wang, Y., Jin, F., Zhang, Y., Yang, L., Wu, X., Wu, Y."Silencing of RegIV by shRNA causes the loss of stemness properties of cancer stem cells in MKN45 gastric cancer cells". Oncology Reports 30, no. 6 (2013): 2685-2690. https://doi.org/10.3892/or.2013.2745
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team